• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子诱饵受体D6对CC趋化因子的识别与适应性上调及降解取决于其N端序列。

Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.

作者信息

Savino Benedetta, Borroni Elena Monica, Torres Nina Machado, Proost Paul, Struyf Sofie, Mortier Anneleen, Mantovani Alberto, Locati Massimo, Bonecchi Raffaella

机构信息

Department of Translational Medicine, University of Milan, 20089 Milan, Italy.

出版信息

J Biol Chem. 2009 Sep 18;284(38):26207-15. doi: 10.1074/jbc.M109.029249. Epub 2009 Jul 24.

DOI:10.1074/jbc.M109.029249
PMID:19632987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2758019/
Abstract

The chemokine decoy receptor D6 controls inflammatory responses by selective recognition and degradation of most CCR1 to CCR5 agonistic ligands. CCL14 is a homeostatic chemokine present at high concentrations in the serum with a weak agonist activity on CCR1. Under inflammatory conditions, plasmin and UPA-mediated truncation of 8 amino acids generates the potent CCR1/CCR3/CCR5 isoform CCL14(9-74), which is further processed and inactivated by dipeptidyl peptidase IV/CD26 that generates CCL14(11-74). Here we report that D6 efficiently binds both CCL14 and its truncated isoforms. Like other D6 ligands, the biologically active CCL14(9-74) induces adaptive up-regulation of D6 expression on the cell membrane and is rapidly and efficiently degraded. In contrast, the D6-mediated degradation of the biologically inactive isoforms CCL14(1-74) and CCL14(11-74) is very inefficient. Thus, D6 cooperates with CD26 in the negative regulation of CCL14 by the selective degradation of its biologically active isoform. Analysis of a panel of CC chemokines and their truncated isoforms revealed that D6-mediated chemokine degradation does not correlate with binding affinity. Conversely, degradation efficiency is positively correlated with D6 adaptive up-regulation. Sequence analysis indicated that a proline residue in position 2 of D6 ligands is dispensable for binding but crucial for D6 adaptive up-regulation and efficient degradation.

摘要

趋化因子诱饵受体D6通过选择性识别和降解大多数CCR1至CCR5激动剂配体来控制炎症反应。CCL14是一种稳态趋化因子,在血清中浓度较高,对CCR1具有弱激动剂活性。在炎症条件下,纤溶酶和尿激酶型纤溶酶原激活剂介导的8个氨基酸的截短产生了强效的CCR1/CCR3/CCR5同种型CCL14(9-74),其进一步被二肽基肽酶IV/CD26加工并失活,生成CCL14(11-74)。在此我们报告,D6能有效结合CCL14及其截短的同种型。与其他D6配体一样,具有生物活性的CCL14(9-74)诱导细胞膜上D6表达的适应性上调,并迅速且有效地被降解。相比之下,D6介导的无生物活性同种型CCL14(1-74)和CCL14(11-74)的降解效率非常低。因此,D6通过选择性降解其生物活性同种型与CD26协同对CCL14进行负调控。对一组CC趋化因子及其截短同种型的分析表明,D6介导的趋化因子降解与结合亲和力无关。相反,降解效率与D6适应性上调呈正相关。序列分析表明,D6配体第2位的脯氨酸残基对于结合并非必需,但对于D6适应性上调和有效降解至关重要。

相似文献

1
Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.趋化因子诱饵受体D6对CC趋化因子的识别与适应性上调及降解取决于其N端序列。
J Biol Chem. 2009 Sep 18;284(38):26207-15. doi: 10.1074/jbc.M109.029249. Epub 2009 Jul 24.
2
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.D6诱饵受体对天然和截短型巨噬细胞源性趋化因子(巨噬细胞源性趋化因子/CC趋化因子配体22)的差异识别与清除
J Immunol. 2004 Apr 15;172(8):4972-6. doi: 10.4049/jimmunol.172.8.4972.
3
n-Nonanoyl-CC chemokine ligand 14, a potent CC chemokine ligand 14 analogue that prevents the recruitment of eosinophils in allergic airway inflammation.正壬酰基-CC趋化因子配体14,一种有效的CC趋化因子配体14类似物,可防止嗜酸性粒细胞在过敏性气道炎症中募集。
J Immunol. 2004 Sep 1;173(5):3456-66. doi: 10.4049/jimmunol.173.5.3456.
4
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.前沿:由多特异性的假定沉默趋化因子受体D6清除炎症性CC趋化因子
J Immunol. 2003 Mar 1;170(5):2279-82. doi: 10.4049/jimmunol.170.5.2279.
5
CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14).非糖胺聚糖(非-GAG)结合型非壬酰化 CCL14(NNY-CCL14)对白细胞的 CCR1 和 CCR5 介导的失活作用。
J Leukoc Biol. 2010 Aug;88(2):383-92. doi: 10.1189/jlb.0509366. Epub 2010 May 18.
6
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation.通过配体和Rab11依赖性表面上调对D6趋化因子清除活性的调节。
Blood. 2008 Aug 1;112(3):493-503. doi: 10.1182/blood-2007-08-108316. Epub 2008 May 14.
7
Glycosylation Regulates N-Terminal Proteolysis and Activity of the Chemokine CCL14.糖基化调节趋化因子 CCL14 的 N 端蛋白水解和活性。
ACS Chem Biol. 2021 Jun 18;16(6):973-981. doi: 10.1021/acschembio.1c00006. Epub 2021 May 14.
8
Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.人CC趋化因子CCL15/HCC-2(一种高亲和力CCR1配体)化学合成衍生物的功能分析
J Pept Res. 2004 Jan;63(1):36-47. doi: 10.1046/j.1399-3011.2004.00102.x.
9
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines.趋化因子受体D6持续地在细胞表面往返运输,以内化和降解趋化因子。
Mol Biol Cell. 2004 May;15(5):2492-508. doi: 10.1091/mbc.e03-09-0634. Epub 2004 Mar 5.
10
Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation.趋化因子清除受体D6在平衡炎症与免疫激活中的作用。
Methods Enzymol. 2009;460:231-43. doi: 10.1016/S0076-6879(09)05211-2.

引用本文的文献

1
GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity.GPR182 是一种广泛清除的非典型趋化因子受体,影响 T 细胞非依赖性免疫。
Front Immunol. 2023 Jul 24;14:1242531. doi: 10.3389/fimmu.2023.1242531. eCollection 2023.
2
Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.健康小鼠中趋化因子受体非典型定位的解剖学图谱。
PLoS Biol. 2023 May 9;21(5):e3002111. doi: 10.1371/journal.pbio.3002111. eCollection 2023 May.
3
New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.新型趋化因子受体家族配体及其孤儿受体的鉴定——生理和临床相关性。
Front Immunol. 2023 Apr 20;14:1133394. doi: 10.3389/fimmu.2023.1133394. eCollection 2023.
4
CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6.趋化因子CXCL10是CC家族趋化因子清除受体ACKR2/D6的激动剂。
Cancers (Basel). 2021 Mar 2;13(5):1054. doi: 10.3390/cancers13051054.
5
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.CC 趋化因子在肿瘤中的作用:配体 CCR1、CCR2、CCR3 和 CCR4 的促癌和抗癌特性综述。
Int J Mol Sci. 2020 Nov 9;21(21):8412. doi: 10.3390/ijms21218412.
6
Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2.β-抑制蛋白1/肌球蛋白Vb信号传导对细胞骨架动力学的控制调节非典型趋化因子受体ACKR2的内体分选和清除活性。
Vaccines (Basel). 2020 Sep 17;8(3):542. doi: 10.3390/vaccines8030542.
7
Comparison of Inflammatory Effects in THP-1 Monocytes and Macrophages after Exposure to Metal Ions.暴露于金属离子后THP-1单核细胞和巨噬细胞炎症效应的比较。
Materials (Basel). 2020 Mar 5;13(5):1150. doi: 10.3390/ma13051150.
8
Adaptation and Constraint in the Atypical Chemokine Receptor Family in Mammals.哺乳动物中非典型趋化因子受体家族的适应与约束。
Biomed Res Int. 2018 Sep 24;2018:9065181. doi: 10.1155/2018/9065181. eCollection 2018.
9
Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.中性粒细胞:脓毒性关节炎有益和有害的细胞。
Int J Mol Sci. 2018 Feb 5;19(2):468. doi: 10.3390/ijms19020468.
10
Mechanisms of Regulation of the Chemokine-Receptor Network.趋化因子受体网络的调控机制
Int J Mol Sci. 2017 Feb 7;18(2):342. doi: 10.3390/ijms18020342.

本文引用的文献

1
The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.淋巴系统通过趋化因子诱饵受体 D6 控制肠道炎症和炎症相关的结肠癌。
Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20.
2
Chemokines and chemokine receptors: an overview.趋化因子与趋化因子受体:概述
Front Biosci (Landmark Ed). 2009 Jan 1;14(2):540-51. doi: 10.2741/3261.
3
Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.趋化因子裂解可抵消MCP-2/CCL8活性的协同上调作用,从而限制其炎症和抗肿瘤效应。
Eur J Immunol. 2009 Mar;39(3):843-57. doi: 10.1002/eji.200838660.
4
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.趋化因子诱饵受体D6在造血细胞中的表达是动态的,并受GATA1调控。
J Immunol. 2008 Dec 1;181(11):8171-81. doi: 10.4049/jimmunol.181.11.8170-a.
5
Regulation of chemokine activity by posttranslational modification.通过翻译后修饰对趋化因子活性的调控。
Pharmacol Ther. 2008 Nov;120(2):197-217. doi: 10.1016/j.pharmthera.2008.08.006. Epub 2008 Aug 28.
6
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.肽基精氨酸脱亚氨酶对CXCL8的瓜氨酸化改变了受体的使用方式,阻止了蛋白水解,并减轻了组织炎症。
J Exp Med. 2008 Sep 1;205(9):2085-97. doi: 10.1084/jem.20080305. Epub 2008 Aug 18.
7
Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection.趋化因子诱饵受体D6在平衡结核分枝杆菌感染中的炎症、免疫激活和抗菌耐药性方面的作用。
J Exp Med. 2008 Sep 1;205(9):2075-84. doi: 10.1084/jem.20070608. Epub 2008 Aug 11.
8
Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding.小分子激动剂通过变构结合与正构结合对CC趋化因子受体1的不同内源性趋化因子的正向与负向调节。
J Biol Chem. 2008 Aug 22;283(34):23121-8. doi: 10.1074/jbc.M803458200. Epub 2008 Jun 17.
9
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation.通过配体和Rab11依赖性表面上调对D6趋化因子清除活性的调节。
Blood. 2008 Aug 1;112(3):493-503. doi: 10.1182/blood-2007-08-108316. Epub 2008 May 14.
10
Structural and functional characterization of CC chemokine CCL14.CC趋化因子CCL14的结构与功能特性
Biochemistry. 2007 Sep 4;46(35):10008-15. doi: 10.1021/bi700936w. Epub 2007 Aug 11.